• Login
    • Advanced search
    • Title
    • Channel
    • Module
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transportation and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
Hogan Lovells Engage 5.7.26
      • Title
      • Channel
      • Module
    • Hit ENTER to search in content
    • Advanced search
    • Login
  • Home
  • Industry
    •  

      • Aerospace, Defense, and Government Services
      • Automotive and Mobility
      • Consumer
      • Manufacturing and Industrials
      • Education
      • Energy and Natural Resources
      • Financial Institutions
    •  

      • Insurance
      • Life Sciences and Health Care
      • Private Capital
      • Real Estate
      • Sports, Media and Entertainment
      • Technology and Telecoms
      • Transportation and Logistics
  • Practice
    • Corporate & Finance

      • Banking and Loan Finance
      • Business Restructuring and Insolvency
      • Capital Markets
      • Corporate Governance and Public Company Representation
      • Digital Assets and Blockchain
      • Infrastructure, Energy, Resources, and Projects
      • Leveraged and Acquisition Finance
      • Mergers and Acquisitions
      • Pensions
      • Private Equity, Venture Capital and Investment Funds
      • Real Estate
      • Real Estate Investment Trusts (REITs)
      • Tax
      • Transfer Pricing
    • Global Regulatory

      • Administrative and Public Law
      • Antitrust and Competition
      • Communications, Internet, and Media
      • Education
      • Energy Regulatory
      • Environment and Natural Resources
      • Financial Services
      • Food Law
      • Gaming Law
      • Government Contracts and Public Procurement
      • Government Relations and Public Affairs
      • Health
      • Immigration
      • International Trade and Investment
      • Medical Device and Technology Regulatory
      • New Nuclear
      • Pharmaceuticals and Biotechnology Regulatory
      • Privacy and Cybersecurity
      • Space and Satellite
      • Strategic Operations, Agreements and Regulation
      • Transportation Regulatory
    • Intellectual Property

      • Copyright
      • Designs
      • Domain Names
      • IP and Technology Transactions
      • IP Enforcement
      • Patents
      • Trade Secrets and Confidential Know-how
      • Trademarks and Brands
      • Unfair Competition
    • Litigation, Arbitration, and Employment

      • Business and Human Rights
      • Construction and Engineering
      • Corporate and Securities Litigation
      • Employment
      • International Arbitration
      • Investigations, White Collar, and Fraud
      • Products Law
      • Risks, Disputes, and Litigation
  • Comparative guides
  • Engage Premium
  • Login
  • Register
  1. News
  2. EU Member States agree on interoperability specifications for national COVID-19 tracing apps

EU Member States agree on interoperability specifications for national COVID-19 tracing apps

24 June 2020
    • Share by email
    • Share on
    • Twitter
    • LinkedIn
    • Get link
    • Get QR Code
    • Download
    • Print

Digital tools such as mobile apps with warning and tracing functionalities that identify contacts of confirmed COVID-19 infections are said to be crucial for alerting users to the risk of infection and helping to interrupt infection chains. Such apps can help identifying more contacts and significantly accelerate the overall process of combating COVID-19. In a number of countries, both within the EU and globally, national authorities have announced or even already implemented Tracing Apps with different functionalities to support the fight against COVID-19 (e.g. immuni in Italy and Corona-Warn-App in Germany). With the on-going lifting of travel restrictions and border controls in the EU, Tracing Apps will take on greater importance in the upcoming summer travel season.

Index
  1. Issue: Individual solutions on national level
  2. Potential solution: Technical specifications for cross-border exchange of information
  3. Storage of user information
  4. The importance of interoperability and common safety standards

Issue: Individual solutions on national level

The backends (= data processing and storage in the background; counterpart of the frontend, which describes the visible surface of apps) behind the different national Tracing Apps currently do not exchange information. This is unfortunate, as neither the COVID-19 virus nor EU citizens enjoying their freedom of movement stop at national borders. It would be preferable that Tracing Apps developed and deployed at national level remain functional even when users travel to another EU member state. In order to ensure maximum effectiveness, it is essential that users don’t have to download different national apps when travelling across Europe.

Potential solution: Technical specifications for cross-border exchange of information

To come up with a potential solution, the EU Member States, supported by the EU Commission, recently agreed on a set of technical specifications to ensure a safe exchange of information between national Tracing Apps. This set of technical specifications was elaborated by the eHealth Network, a voluntary network set up under article 14 of Directive 2011/24/EU providing a platform of Member States' competent authorities dealing with eHealth. These technical specifications are laid down in the Guidelines by the eHealth Network on interoperability specifications for cross-border transmission chains between approved Tracing Apps ("eHealth Network Guidelines"), published on 16 June 2020.

The model adopted by the eHealth Network Guidelines is a Federation Gateway Service. The eHealth Network considers this to be the least complex and most robust way to connect the backends behind all the different national Tracing Apps. It accepts diagnostic keys from all EU-member states and provides them for all EU-countries for download. With the Federation Gateway Service, each mobile device communicates with the corresponding national backend. Each national backend uploads the diagnostic keys of its users with confirmed infection every few hours and downloads the diagnosis keys from other member states participating in this system. The Federation Gateway Service synchronizes the diagnostic keys across all national backend servers.

 

The eHealth Network visualizes the Federation Gateway Service as follows: If an app user in country A receives a positive test result, a diagnostic key is sent to the corresponding national backend of the Tracing App in country A. The diagnostic key is then uploaded to the Federation Gateway Service, downloaded from the backend in country B, and finally downloaded by users in country B who have traveled to country A. However, only those users in country B who have had close contact with the infected person in country A will receive a warning of possible exposure.

 

Storage of user information

According to the adopted eHealth Network Guidelines, the Federation Gateway Service stores the information of the currently infected users and the countries they have visited, but it does not know the true identity of those users, and it does not know who has come near the infected users. Further, the exchange of data is encrypted so that it is not possible to identify individuals.

The importance of interoperability and common safety standards

The establishment of common eHealth Network Guidelines for the cross-border exchange of information could help in the pan-European fight against the COVID-19 crisis. Of course, the Federation Gateway Service first needs to be set up and the national Tracing Apps need to be established/updated before a cross-border tracing becomes reality. However, the successful cooperation and implementation of the eHealth Network Guidelines in the Member States could also lay the foundation for other future digital health projects on European level. In fact, the EU Commission has already recognized the importance of interoperability between eHealth applications in 2012 in it's so called eHealth Action Plan. According to this plan, the benefits of interoperable eHealth solutions range from improved quality and safety of care through strengthened coordination, up-to-date patient status information and evidence-based clinical guidelines to support decision-making procedures, enhanced safety of treatments received, delivery of care at the point of need, integrated care including quality and safe treatment abroad and, of course, significantly lower implementation and integration costs, opening up competition and reducing costs for developers. The fight against the COVID-19 pandemic could mark an important step towards common standards for interoperability, quality and safety of digital health services in the EU.

Authored by Matthias Schweiger, Stefan Mayr and Katrin Weixlgartner

 

Contacts
Matthias Schweiger
Partner
Munich
Stefan Mayr
Associate
Munich
Index
  1. Issue: Individual solutions on national level
  2. Potential solution: Technical specifications for cross-border exchange of information
  3. Storage of user information
  4. The importance of interoperability and common safety standards
Keywords COVID-19, contact tracing, Europe
Languages English
Topics COVID-19, Digital Health, Advertising and Promotion of Pharmaceuticals and Biotechnology, Advertising and Promotion of Medical Devices
Countries Belgium, France, Germany, Hungary, Italy, Luxembourg, Netherlands, Poland, Spain, United Kingdom
Delete Comment ?

Are you sure want to delete comment ?

Get link
Embed
Share by email
Get QR Code

Scan this QR Code to share this content

  • Contact us
  • Disclaimer
  • Privacy
  • Cookies
  • Legal Notices
  • Terms of Use

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2022 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.

Thomson Reuters HighQ Logo
© 2023 Hogan Lovells | Privacy Policy | Terms of Service